Dedicated kidney disease‐focused outcome trials with sodium‐glucose cotransporter‐2 inhibitors: Lessons from CREDENCE and expectations from DAPA‐HF, DAPA‐CKD, and EMPA‐KIDNEY-Reference-Cited by-同舟云学术

Dedicated kidney disease‐focused outcome trials with sodium‐glucose cotransporter‐2 inhibitors: Lessons from CREDENCE and expectations from DAPA‐HF, DAPA‐CKD, and EMPA‐KIDNEY

Published:2020-04 Issue:S1 Volume:22 Page:46-54
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Rhee Jinnie J.¹²^ORCID,Jardine Meg J.³⁴,Chertow Glenn M.¹²⁵,Mahaffey Kenneth W.²⁶⁷

Affiliation:

1. Division of Nephrology, Department of MedicineStanford University School of Medicine Stanford California United States

2. Stanford Diabetes Research CenterStanford University School of Medicine Stanford California United States

3. The George Institute for Global HealthUNSW Sydney New South Wales Australia

4. Department of Renal MedicineConcord Repatriation General Hospital Sydney Australia

5. Department of Epidemiology and Population HealthStanford University School of Medicine Stanford California United States

6. Division of Cardiovascular MedicineStanford University School of Medicine Stanford California United States

7. Stanford Center for Clinical ResearchStanford University School of Medicine Stanford California United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13987

Reference46 articles.

1. Diabetic Kidney Disease

2. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016

3. Kidney Disease and Increased Mortality Risk in Type 2 Diabetes

4. Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling

5. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of dapagliflozin plus standard treatment compared to standard therapy for the management of chronic kidney disease in Colombia;Expert Review of Pharmacoeconomics & Outcomes Research;2024-07-24

2. SA-β-Gal in Kidney Tubules as a Predictor of Renal Outcome in Patients with Chronic Kidney Disease;Journal of Clinical Medicine;2024-01-06

3. Indicators of biochemical control of diabetes mellitus during limited availability of health service in the context of hypoglycemic therapy;Wiadomości Lekarskie;2024

4. Advances in the management of chronic kidney disease – a South African perspective;Wits Journal of Clinical Medicine;2024

5. One-year mortality after hospitalization for acute heart failure: Predicting factors (PRECIC study subanalysis);Revista Portuguesa de Cardiologia;2023-06